1791 Results for "

Compound C

" in MedChemExpress (MCE) Product Catalog:
Products (1791)

1791 Results for "Compound C" in MCE Product Catalog:

819
819 Publications Verification
Cat. No.: HY-13418A
CAS No.: 866405-64-3
Purity:  99.10%
Synonyms: BML-275
Research Areas:  

Cancer

Dorsomorphin (BML-275) is a selective and ATP-competitive AMPK inhibitor (Ki=109 nM in the absence of AMP). Dorsomorphin (BML-275) selectively inhibits BMP type I receptors ALK2, ALK3, and ALK6. Dorsomorphin can reverse autophagy activation and anti-inflammatory effect of Urolithin A (HY-100599) .
loading...
    loading...
819
819 Publications Verification
Cat. No.: HY-13418
CAS No.: 1219168-18-9
Purity:  99.7%
Synonyms: Compound C dihydrochloride; BML-275 dihydrochloride
Dorsomorphin (Compound C) dihydrochloride is a potent, selective and ATP-competitive AMPK inhibitor, with a Ki of 109 nM. Dorsomorphin dihydrochloride inhibits BMP pathway by targeting the type I receptors ALK2, ALK3, and ALK6. Dorsomorphin dihydrochloride can reverse autophagy activation and anti-inflammatory effect of Urolithin A (HY-100599).
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-123999
CAS No.: 1700637-55-3
Purity:  99.26%
Target:  

CD38

Research Areas:  

Metabolic Disease

CD38 inhibitor 1 (compound 78c) is a potent CD38 inhibitor with IC50s of 7.3 nM and 1.9 nM for hCD38 and mouse CD38 .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-12682
CAS No.: 311795-38-7
Purity:  99.88%
Synonyms: Compound 968
Target:  

Glutaminase

Research Areas:  

Cancer

Glutaminase C-IN-1 (Compound 968) is an allosteric inhibitor of Glutaminase C that inhibits cancer cell growth without affecting their normal cellular counterparts .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-130592
CAS No.: 848035-21-2
Purity:  99.95%
Synonyms: C48/80 trihydrochloride
Target:  

Phospholipase

Research Areas:  

Neurological Disease

Compound 48/80 trihydrochloride (C48/80 trihydrochloride) is a mixture of condensation products of N-methyl-p-methoxyphenethylamine with formaldehyde. Compound 48/80 trihydrochloride is also a histamine releaser and a mast cell degranulator. Compound 48/80 inhibits phosphatidylinositol-specific phospholipase C activity from human platelets .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-13977A
CAS No.: 608512-97-6
Purity:  99.27%
Target:  

Apoptosis

Research Areas:  

Neurological Disease

PKR-IN-C16 (Compound C16) is a specific double-stranded RNA-dependent protein kinase (PKR) inhibitor. PKR-IN-C16 shows promising neuroprotective properties and can rescue acute brain lesions .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-115768
CAS No.: 94724-12-6
Purity:  99.98%
Synonyms: Poly-p-methoxyphenethylmethylamine
Target:  

Phospholipase

Research Areas:  

Neurological Disease Cancer

Compound 48/80 (Poly-p-methoxyphenethylmethylamine) is widely used in animal and tissue models as a "selective" mast cell activator. Compound 48/80 acts at the mast cell membrane to stimulate trimeric G-proteins and induces degranulation via phospholipase C and D pathways .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-50737
CAS No.: 924296-17-3
DUB-IN-3 (compound 22c) is a potent and selective inhibitor of the deubiquitinating enzyme USP8 with an IC50 value of 0.56 μM. DUB-IN-3 is promising for research of cancer, neurodegenerative diseases, inflammation, viral infection and cardiovascular disease .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-115364
CAS No.: 14255-87-9
Purity:  99.87%
Synonyms: SKF 29044
Parbendazole (SKF‑29044) is an orally active benzimidazole carbamate compound with multiple biological activities. Parbendazole binds to free tubulin and inhibits microtubule polymerization; it also activates the JNK/c‑Jun signaling axis and upregulates the expression of the downstream axonal repulsion factor Sema3A. Parbendazole upregulates KAL-1 mRNA expression, reduces nerve growth factor levels, and promotes the terminal differentiation of normal human epidermal keratinocytes. Parbendazole induces apoptosis in differentiated acute myeloid leukemia monocytes and exerts antileukemic activity in a mouse xenograft model of acute myeloid leukemia. Parbendazole exhibits broad-spectrum anthelmintic activity against various animal nematodes. Parbendazole is used in research related to acute myeloid leukemia and parasitic infections .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-100445
CAS No.: 1689540-62-2
Purity:  99.51%
Target:  

Integrin

Research Areas:  

Cardiovascular Disease Cancer

αvβ1 integrin-IN-1 (Compound C8) is a potent and selective αvβ1 integrin inhibitor with an IC50 of 0.63 nM. Antifibrotic effects .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-100445A
Purity:  98.28%
Target:  

Integrin

Research Areas:  

Cardiovascular Disease Cancer

αvβ1 integrin-IN-1 TFA (Compound C8) is a potent and selective αvβ1 integrin inhibitor with an IC50 of 0.63 nM. Antifibrotic effects .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-N0205
CAS No.: 129741-57-7
Synonyms: Anemoside B4
Pulchinenoside C (Anemoside B4) is a natural compound of the herbaceous peony saponin B4, which has many biological effects, such as antitumor, neuroprotective, and anti-angiogenic activities.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-N0904
CAS No.: 39262-14-1
Synonyms: Ginsenoside Compound K; Ginsenoside K
Ginsenoside C-K, a bacterial metabolite of G-Rb1, exhibits anti-inflammatory effects by reducing iNOS and COX-2. Ginsenoside C-K exhibits an inhibition against the activity of CYP2C9 and CYP2A6 in human liver microsomes with IC50s of 32.0±3.6 μM and 63.6±4.2 μM, respectively.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-149992
CAS No.: 2911609-80-6
Purity:  99.95%
Target:  

MyD88

Research Areas:  

Inflammation/Immunology Cancer

MyD88-IN-1 (Compound c17) is an orally active MyD88 inhibitor. MyD88-IN-1 inhibits the interaction of TLR4 and MyD88 and suppressed the NF-κB pathway. MyD88-IN-1 can be used in research of cancer and inflammatory .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-111753A
CAS No.: 2749300-35-2
Purity:  99.87%
Target:  

WDR5 Apoptosis

Research Areas:  

Cancer

WDR5-IN-4 TFA (Compound C6) is an inhibitor of the WIN site of chromatin-associated WD repeat-containing protein 5 (WDR5), with a Kd of 0.1 nM. WDR5-IN-4 TFA displaces WDR5 from chromatin and decreases the expression of associated genes, causing translational inhibition, nucleolar stress. Anti-cancer activity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-111753
CAS No.: 2407457-36-5
Purity:  98.13%
Target:  

WDR5 Apoptosis

Research Areas:  

Cancer

WDR5-IN-4 (Compound C6) is a WIN site inhibitor of chromatin-associated WD repeat domain 5 protein (WDR5), Kd The value is 0.1 nM. WDR5-IN-4 is able to displace WDR5 from chromatin and reduce the expression of related genes, causing translation inhibition and nucleolar stress. Has anti-cancer effects .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-N0853
CAS No.: 19885-10-0
Alisol A is an orally active tetracyclic triterpenoid compound of the prototerpane type. Alisol A can be extracted from the rhizome of Alisma orientale. Alisol A activates AMPK/ACC/SREBP-1c, SIRT1, PPARα, inhibits MMP-2/-9, decreases inflammatory cytokine expression (IL-1β, IL-6, IL-8). Alisol A has anti-tumor activity against breast cancer and colorectal cancer. Alisol A has anti-obesity and anti-atherosclerotic activities. Alisol A can be used in the research of hepatitis B, breast cancer, colorectal cancer, atherosclerosis, and obesity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-N0777
CAS No.: 5041-82-7
Isorhamnetin-3-O-glucoside is an orally active natural compound. Isorhamnetin 3-O-glucoside increases P-ERK, ERK, P-Akt (Ser473), P-PI3K, and PDX-1. Isorhamnetin 3-O-glucoside downregulates C/EBPα and inhibits lipase. Isorhamnetin 3-O-glucoside reduces lipids and inhibits obesity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-130254
CAS No.: 2380027-49-4
Purity:  98.04%
Target:  

Src

Research Areas:  

Inflammation/Immunology Cancer

CSK-IN-1 (compound 13) is a potent, orally active c-terminal Src kinase (CSK) with IC50 values below 3 nM and 4 nM in CSK HTRF and Caliper assay, respectively. CSK-IN-1 shows the ability to increase T cell proliferation induced by T cell receptor signaling .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-N0498
CAS No.: 13063-04-2
Nitidine chloride, a potential anti-malarial lead compound derived from Zanthoxylum nitidum (Roxb) DC, exerts potent anticancer activity through diverse pathways, including inducing apoptosis, inhibiting STAT3 signaling cascade, DNA topoisomerase 1 and 2A, ERK and c-Src/FAK associated signaling pathway, also has anti-inflammatory activity. Nitidine chloride inhibits LPS-induced inflammatory cytokines production via MAPK and NF-kB pathway .
loading...
    loading...